Changzhou Qianhong Biopharma CO.,LTD
Changzhou Qianhong Biopharma Co., Ltd., commonly referred to as Qianhong Biopharma, is a leading player in the biopharmaceutical industry, headquartered in Changzhou, China. Established in 2003, the company has made significant strides in the development and production of high-quality biopharmaceutical products, particularly in the fields of blood products and recombinant proteins. With a strong operational presence across various regions in China and beyond, Qianhong Biopharma is renowned for its innovative approach to healthcare solutions. The company’s core offerings include a range of plasma-derived therapies and biopharmaceuticals that stand out for their efficacy and safety. Recognised for its commitment to quality and research, Qianhong Biopharma has achieved notable milestones, positioning itself as a trusted name in the global biopharmaceutical market.
DitchCarbon Score
How does Changzhou Qianhong Biopharma CO.,LTD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Changzhou Qianhong Biopharma CO.,LTD's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Changzhou Qianhong Biopharma CO.,LTD's reported carbon emissions
Changzhou Qianhong Biopharma CO., LTD, headquartered in China, currently does not report any specific carbon emissions data for the most recent year, as no emissions figures are available. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, indicating a lack of formal commitments towards carbon footprint reduction or sustainability initiatives at this time. As there is no inherited emissions data from a parent or related organisation, Changzhou Qianhong Biopharma CO., LTD stands independently in its climate strategy. The absence of specific emissions data and reduction initiatives highlights a potential area for growth in environmental accountability and climate action within the biopharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Changzhou Qianhong Biopharma CO.,LTD is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
